Univdatos Whatsapp
Preimplantation genetic testing market

The global preimplantation genetic testing market is expected to foresee significant growth during the forecast period. North America to witness the highest growth

The global preimplantation genetic testing market is expected to grow significantly by 2027 expanding at a reasonable CAGR of around 10% during the forecast period (2021-2027). Preimplantation genetic testing is done before the implantation is achieved and helps in diagnosing various genetic defects present within the embryos. This genetic testing assists in analyzing the genetic profile of embryos which aids in avoiding selective pregnancy termination. 

For a detailed analysis of the preimplantation genetic testing browse through https://univdatos.com/report/preimplantation-genetic-testing-market/

The global preimplantation genetic testing market is anticipated to witness an uptick owing to the advancement in technology in genetic testing and rising incidences of chromosomal abnormalities with the rising cases of late pregnancies. For instance, in America, the average age of first-time mothers is now up from 21 to 26, while for fathers, it’s increased from 27 to 31. Apart from America, the average age for first birth happening for new mothers is 31 in other developed countries. This increasing maternal age all over the world is leading to a high risk of chromosomal abnormalities. The chance of having a child affected by Down syndrome increases from about 1 in 1,250 for a woman who conceives at age 25, to about 1 in 100 for a woman who conceives at age 40. Furthermore, the increasing number of fertility clinics globally, subsequent innovations in genetic diagnosis, and the number of supportive government initiatives are some of the other factors propelling the growth of the market.

For a detailed analysis of the market drivers of preimplantation genetic testing browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=18509

Based on product & services, the market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment grabbed an XX% share of the global preimplantation genetic testing market and will witness a considerable CAGR of XX% during the forecast period (2021-2027F). This is because of the growing applications of specific technologies such as NGS, FISH, etc. for the diagnosis of genetic disorders.

Based on the technology, the global preimplantation genetic testing market is segmented into next-generation sequencing, polymerase chain reaction, fluorescent in-situ hybridization, comparative genomic hybridization, and single nucleotide polymorphism. The next-generation sequencing occupied a substantial share and is expected to grow at a CAGR of XX% during the forecast period 2021-2027 as it is essential for successful embryo transfer and achieving pregnancy, thus plummeting the time and cost.

Request for Sample of the report browse through https://univdatos.com/get-a-free-sample-form-php/?product_id=18509

Additionally, the report provides detailed report also provides insights into the global preimplantation genetic testing market according to the regions such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, India, Australia, Japan, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to the well-established market players and frequent product launches.

Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Illumina, Inc., The Cooper Companies Inc., Bioarray S.L., Natera Inc., Quest Diagnostics Inc., Laboratory Corporation of America Holdings, F. Hoffmann-La Roche AG, are some of the key players operating in the global preimplantation genetic testing market. Several M&As along with partnerships have been undertaken by these players to develop new and advanced preimplantation genetic testing devices.

Global Preimplantation Genetic Testing Market Segmentation

Market Insight, by Product & Services

  • Reagents & Consumables
  • Instruments
  • Software & Services

Market Insight, by Technology

  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Fluorescent In-Situ Hybridization
  • Comparative Genomic Hybridization
  • Single Nucleotide Polymorphism

Market Insight, by Procedure Type

  • Preimplantation Genetic Screening
  • Preimplantation Genetic Diagnosis

Market Insight, by Application

  • Aneuploidy
  • Structural Chromosomal Abnormalities
  • Single Gene Disorders
  • X-linked Disorders
  • HLA Typing
  • Gender Identification

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Australia
    • Japan
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Thermo Fisher Scientific Inc.
  • Agilent Technologies Inc.
  • PerkinElmer Inc.
  • Illumina, Inc.
  • The Cooper Companies Inc.
  • Bioarray S.L
  • Natera Inc.
  • Quest Diagnostics Inc.
  • Laboratory Corporation of America Holdings
  • F. Hoffmann-La Roche AG

Leave A Comment

Select Language